Skip to content

Author

Qingshan Li

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

The Synergistic Inhibition of IRF4/NF-κB/STAT3 Pathway by Lenalidomide Combined with BTK Inhibitor Enhances the Effect of Rituximab on Apoptosis in ABC Type Diffuse Large B-cell Lymphoma

AIM: Activated B-cell like diffuse large B-cell lymphoma (ABC-DLBCL) has poor response to standard rituximab combined chemotherapy regimen and poor clinical prognosis. The aim of this study is to investigate the in vitro experimental basis for the clinical application of the three-drug combination (Zanubrutinib, Lenali...

Ting Wei, Xiaoting Liao, Yue Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.